Correction to: Role of Hippo pathway dysregulation from gastrointestinal premalignant lesions to cancer
Giulia Schiavoni,
Beatrice Messina,
Stefano Scalera,
Lorenzo Memeo,
Cristina Colarossi,
Marzia Mare,
Giovanni Blandino,
Gennaro Ciliberto,
Giulia Bon,
Marcello Maugeri-Saccà
Affiliations
Giulia Schiavoni
Clinical Trial Center, Biostatistics and Bioinformatics Unit, Department of Research, Diagnosis and Innovative Technologies, IRCCS Regina Elena National Cancer Institute
Beatrice Messina
Clinical Trial Center, Biostatistics and Bioinformatics Unit, Department of Research, Diagnosis and Innovative Technologies, IRCCS Regina Elena National Cancer Institute
Stefano Scalera
SAFU Laboratory, Department of Research, Advanced Diagnostic, and Technological Innovation, IRCCS Regina Elena National Cancer Institute
Lorenzo Memeo
Pathology Unit, Mediterranean Institute of Oncology
Cristina Colarossi
Pathology Unit, Mediterranean Institute of Oncology
Marzia Mare
Medical Oncology Unit, Mediterranean Institute of Oncology
Giovanni Blandino
Translational Oncology Research Unit, Department of Research, Diagnosis and Innovative Technologies, IRCCS Regina Elena National Cancer Institute
Gennaro Ciliberto
Scientific Directorate, IRCCS Regina Elena National Cancer Institute
Giulia Bon
Cellular Network and Molecular Therapeutic Target Unit, Department of Research, Diagnosis and Innovative Technologies, IRCCS Regina Elena National Cancer Institute
Marcello Maugeri-Saccà
Clinical Trial Center, Biostatistics and Bioinformatics Unit, Department of Research, Diagnosis and Innovative Technologies, IRCCS Regina Elena National Cancer Institute
